Panakes Partners

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€20m

Latest public closing

2 Jul 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Milan-based venture capital firm investing in life-sciences companies developing technologies and products to improve health and patient outcomes.

Focus: Life sciences, especially medical devices, diagnostics and healthcare IT; early-stage companies and SMEs in Europe and Israel

2 July 2026: first close of BII Catalyst Fund I for Italy, reported at about €20m with Lazio Innova and Novo Holdings as anchors (company announcement; size per press reporting).